April 27 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Friday that its non-consolidated net profit fell to 11.7 million levs ($7.2 million/6.0 million euro) in the first quarter of 2018 from 12.6 million levs in the like period of last year.